On November 11, 2020 CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody technology platform, reported that Sean McCarthy, D.Phil., president, chief executive officer, and chairman, will participate in the following virtual healthcare conferences in November (Press release, CytomX Therapeutics, NOV 11, 2020, View Source [SID1234570597]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies Virtual London Healthcare Conference
Date: Wednesday, November 18, 2020
Presentation Time: 10:15a.m. ET

32nd Annual Piper Sandler Virtual Healthcare Conference
Date: Monday, November 30, 2020
Presentation Time: November 23, 2020 at 10:00 a.m. ET. The fireside chat will be available for on-demand viewing before the conference.

Webcasts from both conferences will be available on the Events and Presentations page of CytomX’s website at www.cytomx.com. An archived replay will be available for 90 days following the events.